MA48455A - ANTI-CANCER COMPOUNDS - Google Patents

ANTI-CANCER COMPOUNDS

Info

Publication number
MA48455A
MA48455A MA048455A MA48455A MA48455A MA 48455 A MA48455 A MA 48455A MA 048455 A MA048455 A MA 048455A MA 48455 A MA48455 A MA 48455A MA 48455 A MA48455 A MA 48455A
Authority
MA
Morocco
Prior art keywords
cancer compounds
cancer
compounds
Prior art date
Application number
MA048455A
Other languages
French (fr)
Other versions
MA48455B1 (en
Inventor
Marchante Maria Del Carmen Cuevas
Solloso Andres Francesch
Barrasa Valentin Martinez
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Priority claimed from PCT/EP2018/060868 external-priority patent/WO2018197663A1/en
Publication of MA48455A publication Critical patent/MA48455A/en
Publication of MA48455B1 publication Critical patent/MA48455B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995Pyrazines or piperazines forming part of bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA48455A 2017-04-27 2018-04-27 ANTITUMOR COMPOUNDS MA48455B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382228 2017-04-27
PCT/EP2018/060868 WO2018197663A1 (en) 2017-04-27 2018-04-27 Antitumoral compounds

Publications (2)

Publication Number Publication Date
MA48455A true MA48455A (en) 2020-03-04
MA48455B1 MA48455B1 (en) 2023-06-28

Family

ID=58668823

Family Applications (3)

Application Number Title Priority Date Filing Date
MA48455A MA48455B1 (en) 2017-04-27 2018-04-27 ANTITUMOR COMPOUNDS
MA58643A MA58643B1 (en) 2017-04-27 2018-04-27 ANTI-CANCER COMPOUNDS
MA57420A MA57420B1 (en) 2017-04-27 2018-04-27 ANTI-CANCER COMPOUNDS

Family Applications After (2)

Application Number Title Priority Date Filing Date
MA58643A MA58643B1 (en) 2017-04-27 2018-04-27 ANTI-CANCER COMPOUNDS
MA57420A MA57420B1 (en) 2017-04-27 2018-04-27 ANTI-CANCER COMPOUNDS

Country Status (2)

Country Link
AR (1) AR114387A1 (en)
MA (3) MA48455B1 (en)

Also Published As

Publication number Publication date
MA48455B1 (en) 2023-06-28
AR114387A1 (en) 2020-09-02
MA57420B1 (en) 2023-06-28
MA58643B1 (en) 2023-09-27

Similar Documents

Publication Publication Date Title
EP3720430A4 (en) BENZOCARBONYL COMPOUNDS
EP3691623A4 (en) BENZOSULFONYL COMPOUNDS
MA47131A (en) BENZYL-AMIDE PHOSPHODIAMIDE ANTIVIRAL COMPOUNDS
MA49701A (en) IMMUNOMODULATOR COMPOUNDS
EP3532069A4 (en) ARYL-AMIDE PHOSPHODIAMIDE COMPOUNDS ANTIVIRALS
EP3474845A4 (en) IMMUNOMODULATORY COMPOUNDS
MA44020A (en) ANTITUMOR COMPOUNDS
MA44233A (en) NEW COMPOUNDS
MA41614A (en) ANTIVIRAL COMPOUNDS
MA44050A (en) NEW COMPOUNDS
MA42293A (en) ANTIBACTERIAL COMPOUNDS
ME03419B (en) SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS
EP3445750A4 (en) THERAPEUTIC COMPOUNDS
EP3609871A4 (en) ARYL-CYCLOPROPYL-AMINO-ISOCHINOLINYL-AMIDE COMPOUNDS
EP3464336A4 (en) COMPOUNDS
DK3612519T3 (en) PHENYL-2-HYDROXY-ACETYLAMINO-2-METHYL-PHENYL COMPOUNDS
EP3728289A4 (en) OPTIMIZED COMPOUNDS
MA49621A (en) BIFUNCTIONAL COMPOUNDS
EP3310352A4 (en) CRYSTALLINE COMPOUNDS
EP3717483A4 (en) PYRAZOLOPYRIDINONE COMPOUNDS
EP3713941A4 (en) PYRAZOLOPYRIDINONE COMPOUNDS
MA49522A (en) NEW QUINOLEINONE COMPOUNDS
EP3259254A4 (en) THERAPEUTIC COMPOUNDS
MA49885A (en) MACROCYCLIC COMPOUNDS
EP3504269A4 (en) FLUOROELASTOMER COMPOUNDS